Patents by Inventor Geoffrey Heintzelman

Geoffrey Heintzelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-Aminoisoquinoline Compounds
    Publication number: 20070173530
    Abstract: 6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.
    Type: Application
    Filed: January 10, 2007
    Publication date: July 26, 2007
    Applicant: AERIE PHARMACEUTICALS, INC.
    Inventors: Mitchell deLong, Jill Sturdivant, Geoffrey Heintzelman, Susan Royalty
  • ARYLINDENOPYRIDINES AND ARYLINDENOPYRIMIDINES AND RELATED THERAPEUTIC AND PROPHYLACTIC METHODS
    Publication number: 20070155760
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Application
    Filed: November 16, 2006
    Publication date: July 5, 2007
    Inventors: Geoffrey Heintzelman, James Bullington, Kenneth Rupert
  • Arylindenopyridines and related therapeutic and prophylactic methods
    Publication number: 20060154949
    Abstract: This invention provides novel arylindenopyridines of the formula: and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing Adensine A2a receptors or reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.
    Type: Application
    Filed: January 24, 2005
    Publication date: July 13, 2006
    Inventors: Geoffrey Heintzelman, Kristin Averill, John Dodd, Keith Demarest, Yuting Tang, Paul Jackson
  • Arylindenopyridines and related therapeutic and prophylactic methods
    Publication number: 20060009481
    Abstract: This invention provides novel arylindenopyridines of the formula: and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.
    Type: Application
    Filed: August 3, 2005
    Publication date: January 12, 2006
    Inventors: Geoffrey Heintzelman, Kristin Averill, John Dodd
  • Arylindenopyridines and related therapeutic and prophylactic methods
    Publication number: 20050277637
    Abstract: This invention provides novel arylindenopyridines of the formula: and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.
    Type: Application
    Filed: August 4, 2005
    Publication date: December 15, 2005
    Inventors: Geoffrey Heintzelman, Kristin Averill, John Dodd
  • Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
    Publication number: 20050267142
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 1, 2005
    Inventors: Geoffrey Heintzelman, James Bullington, Kenneth Rupert
  • Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
    Publication number: 20050267139
    Abstract: This invention provides methods of treatment using novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 1, 2005
    Inventors: Geoffrey Heintzelman, James Bullington, Kenneth Rupert
  • Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
    Publication number: 20050267138
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 1, 2005
    Inventors: Geoffrey Heintzelman, James Bullington, Kenneth Rupert
  • Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
    Publication number: 20050239810
    Abstract: This invention provides methods of treatment using novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Application
    Filed: June 29, 2005
    Publication date: October 27, 2005
    Inventors: Geoffrey Heintzelman, James Bullington, Kenneth Rupert
  • Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
    Publication number: 20050239812
    Abstract: This invention provides novel arylindenopyridines and arylindenopyrimidines of the formula: wherein R1, R2, R3, R4, and X are as defined above, and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant compounds and pharmaceutical compositions.
    Type: Application
    Filed: June 29, 2005
    Publication date: October 27, 2005
    Inventors: Geoffrey Heintzelman, James Bullington, Kenneth Rupert
  • Arylindenopyridines and related therapeutic and prophylactic methods
    Publication number: 20050239782
    Abstract: This invention provides novel arylindenopyridines of the formula: and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing Adensine A2a receptors or reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.
    Type: Application
    Filed: June 8, 2005
    Publication date: October 27, 2005
    Inventors: Geoffrey Heintzelman, Kristin Averill, John Dodd, Keith Demarest, Yuting Tang, Paul Jackson